Examination of GABAergic and dopaminergic compounds in the acquisition of nicotine-conditioned hyperactivity in rats

Matthew I. Palmatier, Rick A Bevins

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

In rats, a distinct environment repeatedly paired with nicotine (0.421 mg/kg base, s.c.) comes to evoke an increase in activity in the absence of any drug. This hyperactivity indicates a Pavlovian-conditioned association between the environment and nicotine. We investigated whether a dopamine D1 receptor antagonist (SCH- 23390), a D2/D3antagonist (eticlopride) or a GABABagonist (baclofen) would prevent the acquisition of nicotine-conditioned hyperactivity. In saline-pretreated rats, acute nicotine suppressed activity during the conditioning phase (i.e. environment-nicotine pairings); chronic nicotine stimulated activity. Pretreatment with SCH-23390 (0.01 mg/kg, i.p.) attenuated the activating effects of nicotine without affecting controls. Eticlopride (0.03-0.07 mg/kg, i.p.) and baclofen (0.625 and 1.25 mg/kg, i.p.) did not affect nicotine-induced activity in a selective manner. Regardless of the pretreatment drug, rats acquired the environment-nicotine association as indexed in a drug-free test. The inability of SCH-23390 to block the acquisition of nicotine-conditioned locomotor activity is notable because in past research SCH-23390 blocked expression of the learned association.

Original languageEnglish (US)
Pages (from-to)87-94
Number of pages8
JournalNeuropsychobiology
Volume45
Issue number2
DOIs
StatePublished - Mar 25 2002

Fingerprint

Nicotine
eticlopride
Baclofen
Pharmaceutical Preparations
Dopamine D1 Receptors
Dopamine Antagonists
Locomotion
SCH 23390

Keywords

  • Activity
  • Classical conditioning
  • Cravings
  • Dopamine
  • Locomotor
  • Nicotinic acetylcholine
  • Tobacco
  • γ-Aminobutyric acid (GABA)
  • γ-Vinyl-GABA

ASJC Scopus subject areas

  • Neuropsychology and Physiological Psychology
  • Psychiatry and Mental health
  • Biological Psychiatry

Cite this

Examination of GABAergic and dopaminergic compounds in the acquisition of nicotine-conditioned hyperactivity in rats. / Palmatier, Matthew I.; Bevins, Rick A.

In: Neuropsychobiology, Vol. 45, No. 2, 25.03.2002, p. 87-94.

Research output: Contribution to journalArticle

@article{64efc17e18d8441182f17b708efa92c0,
title = "Examination of GABAergic and dopaminergic compounds in the acquisition of nicotine-conditioned hyperactivity in rats",
abstract = "In rats, a distinct environment repeatedly paired with nicotine (0.421 mg/kg base, s.c.) comes to evoke an increase in activity in the absence of any drug. This hyperactivity indicates a Pavlovian-conditioned association between the environment and nicotine. We investigated whether a dopamine D1 receptor antagonist (SCH- 23390), a D2/D3antagonist (eticlopride) or a GABABagonist (baclofen) would prevent the acquisition of nicotine-conditioned hyperactivity. In saline-pretreated rats, acute nicotine suppressed activity during the conditioning phase (i.e. environment-nicotine pairings); chronic nicotine stimulated activity. Pretreatment with SCH-23390 (0.01 mg/kg, i.p.) attenuated the activating effects of nicotine without affecting controls. Eticlopride (0.03-0.07 mg/kg, i.p.) and baclofen (0.625 and 1.25 mg/kg, i.p.) did not affect nicotine-induced activity in a selective manner. Regardless of the pretreatment drug, rats acquired the environment-nicotine association as indexed in a drug-free test. The inability of SCH-23390 to block the acquisition of nicotine-conditioned locomotor activity is notable because in past research SCH-23390 blocked expression of the learned association.",
keywords = "Activity, Classical conditioning, Cravings, Dopamine, Locomotor, Nicotinic acetylcholine, Tobacco, γ-Aminobutyric acid (GABA), γ-Vinyl-GABA",
author = "Palmatier, {Matthew I.} and Bevins, {Rick A}",
year = "2002",
month = "3",
day = "25",
doi = "10.1159/000048682",
language = "English (US)",
volume = "45",
pages = "87--94",
journal = "Neuropsychobiology",
issn = "0302-282X",
publisher = "S. Karger AG",
number = "2",

}

TY - JOUR

T1 - Examination of GABAergic and dopaminergic compounds in the acquisition of nicotine-conditioned hyperactivity in rats

AU - Palmatier, Matthew I.

AU - Bevins, Rick A

PY - 2002/3/25

Y1 - 2002/3/25

N2 - In rats, a distinct environment repeatedly paired with nicotine (0.421 mg/kg base, s.c.) comes to evoke an increase in activity in the absence of any drug. This hyperactivity indicates a Pavlovian-conditioned association between the environment and nicotine. We investigated whether a dopamine D1 receptor antagonist (SCH- 23390), a D2/D3antagonist (eticlopride) or a GABABagonist (baclofen) would prevent the acquisition of nicotine-conditioned hyperactivity. In saline-pretreated rats, acute nicotine suppressed activity during the conditioning phase (i.e. environment-nicotine pairings); chronic nicotine stimulated activity. Pretreatment with SCH-23390 (0.01 mg/kg, i.p.) attenuated the activating effects of nicotine without affecting controls. Eticlopride (0.03-0.07 mg/kg, i.p.) and baclofen (0.625 and 1.25 mg/kg, i.p.) did not affect nicotine-induced activity in a selective manner. Regardless of the pretreatment drug, rats acquired the environment-nicotine association as indexed in a drug-free test. The inability of SCH-23390 to block the acquisition of nicotine-conditioned locomotor activity is notable because in past research SCH-23390 blocked expression of the learned association.

AB - In rats, a distinct environment repeatedly paired with nicotine (0.421 mg/kg base, s.c.) comes to evoke an increase in activity in the absence of any drug. This hyperactivity indicates a Pavlovian-conditioned association between the environment and nicotine. We investigated whether a dopamine D1 receptor antagonist (SCH- 23390), a D2/D3antagonist (eticlopride) or a GABABagonist (baclofen) would prevent the acquisition of nicotine-conditioned hyperactivity. In saline-pretreated rats, acute nicotine suppressed activity during the conditioning phase (i.e. environment-nicotine pairings); chronic nicotine stimulated activity. Pretreatment with SCH-23390 (0.01 mg/kg, i.p.) attenuated the activating effects of nicotine without affecting controls. Eticlopride (0.03-0.07 mg/kg, i.p.) and baclofen (0.625 and 1.25 mg/kg, i.p.) did not affect nicotine-induced activity in a selective manner. Regardless of the pretreatment drug, rats acquired the environment-nicotine association as indexed in a drug-free test. The inability of SCH-23390 to block the acquisition of nicotine-conditioned locomotor activity is notable because in past research SCH-23390 blocked expression of the learned association.

KW - Activity

KW - Classical conditioning

KW - Cravings

KW - Dopamine

KW - Locomotor

KW - Nicotinic acetylcholine

KW - Tobacco

KW - γ-Aminobutyric acid (GABA)

KW - γ-Vinyl-GABA

UR - http://www.scopus.com/inward/record.url?scp=0036118784&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036118784&partnerID=8YFLogxK

U2 - 10.1159/000048682

DO - 10.1159/000048682

M3 - Article

VL - 45

SP - 87

EP - 94

JO - Neuropsychobiology

JF - Neuropsychobiology

SN - 0302-282X

IS - 2

ER -